https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-03-01 08:44:062023-03-01 08:44:06Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-24 09:01:082023-03-07 09:21:55Destiny Pharma plc – Fundraising to raise up to £8 million
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-24 09:00:452023-03-07 09:19:03Destiny Pharm plc – Agreement with Sebela Pharmaceuticals for NTCD-M3
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-02-23 14:08:332023-02-23 14:08:33Novo Holdings invests in water technology company Aquafortus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-02-23 12:07:422023-02-23 12:10:30Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-02-22 10:10:532023-02-22 10:11:31Prof. Molly Stevens receives the Novo Nordisk Prize – Understanding how materials and biology interact has revolutionised healthcare technologies
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-02-21 09:05:032023-02-22 10:14:22Novo Holdings participates in Hemab Therapeutics $135M Series B Financing
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-21 08:04:352023-02-21 08:04:35Methinks receives CE Marked Certification for AI-based stroke triage software
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-02-16 16:11:522023-02-16 16:12:09Zephyrus Innovations announces US FDA approval for its Aeroject™ 3ml safety syringe
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-16 08:37:372023-02-16 08:37:37Leucid Bio provides business update and outlook for 2023
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-15 07:23:022023-02-15 07:23:02Futura Medical to present MED3000 FM71 data at the European Society for Sexual Medicine Congress 2023
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-02-14 16:11:412023-06-14 15:49:26Optimum Expands its Team with Senior Investor Relations and Communications Hires Jonathan Edwards and Hana Malik
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-02-09 10:32:472023-02-09 11:22:17Novo Holdings Venture Investments team Newsletter
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-02-09 09:07:262023-02-09 09:10:12Sequana Medical announces 2022 Full Year Results and 2023 Outlook
https://www.optimumcomms.com/wp-content/uploads/2023/09/WiLD_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-09 09:04:212023-09-27 09:07:07Women in Life Science Denmark announce The First Women in Leadership Network to Support Diversity, Equality and Inclusion across the Life Sciences Industry launched in Denmark
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-02-08 09:56:332023-02-08 09:57:14Structural proteins for the development of sustainable materials: BRAIN Biotech and AMSilk cooperate to develop high-performance bio-based protein fibers
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-08 08:34:512023-02-08 08:34:51Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-02-06 11:50:062023-02-06 11:50:06Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-01 09:18:232023-02-01 09:18:23Sequana Medical announces grant of additional DSR® patent in United States
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-02-01 08:46:142023-02-01 08:46:14Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical OfficerFor more information about Optimum Strategic Communications, please get in touch.
